Intrinsic Value of S&P & Nasdaq Contact Us

Forza Innovations Inc. FORZ OTC

Other OTC • Healthcare • Medical - Devices • US • USD

SharesGrow Score
24/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Forza Innovations Inc. (FORZ) generated $-14.03K in operating cash flow for quarter ending 2023-12-31. After capital expenditures of $0.00, free cash flow was $-14.03K.

Free cash flow margin was -180.8% of revenue. Cash conversion ratio was -0.02x, suggesting some earnings are non-cash.

Criteria supported by this page:

  • HEALTH (0/100, Fail) — weak cash flow raises concerns about debt servicing
  • MOAT (50/100, Partial) — cash flow generation is present but not at levels indicating a wide moat
  • INCOME (10/100) — Cash conversion ratio was -0.02x suggests some earnings are non-cash items

Overall SharesGrow Score: 22/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score
24/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
N/A
No coverage
PAST
0/100
→ Income
HEALTH
0/100
Debt-to-Equity & liquidity
Proven by this page
~
MOAT
50/100
Proven by this page
~
GROWTH
58/100
→ Income
INCOME
10/100
→ Income
Forza Innovations Inc. Cash Flow History
Metric TTM Q2 FY2024 Q1 FY2024 Q4 FY2023 Q3 FY2023
Operating Cash Flow $-863.13K$-14.03K$-645.09K$-42.64K$-161.38K
Capital Expenditure $-82.14M$0.00$0.00$-82.14M$-4.00
Free Cash Flow $-83.01M$-14.03K$-645.09K$-82.19M$-161.38K
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message